Clinical trial
Down Syndrome Speech Intelligibility Diagnostic Treatment Study
NCT04059354 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Down Syndrome Speech Intelligibility Diagnostic Treatment Study
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- September 5, 2019
- Completion date
- February 28, 2020
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.